<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02087592</url>
  </required_header>
  <id_info>
    <org_study_id>LIBRE-F-110013</org_study_id>
    <nct_id>NCT02087592</nct_id>
  </id_info>
  <brief_title>Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers</brief_title>
  <acronym>LIBRE</acronym>
  <official_title>Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2 Mutations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian
      cancer during their lifetime. There is evidence from the literature that for sporadic breast
      cancer disease risk and the course of disease can be significantly influenced by physical
      activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized
      multicenter feasibility trial is that a structured life-style intervention program with
      exercise training and mediterranean diet is feasible and improves the nutritional and fitness
      status as well as the weight, the quality of life and stress reacting capacity.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients successfully completing the intervention program</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stress coping capacity (TICS)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grade of optimism (LOT)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index as a marker of caloric balance</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total fat intake</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximum exercise capacity (VO2max) as a marker of physical fitness</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (SF-36)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity (IPAQ questionnaire)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Anthropometric parameters (waist and hip circumference, skinfold measurements)</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Body composition (body impedance analysis)</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Eating behaviour</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameters</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Aerobic exercise capacity during ergometry</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Hereditary Breast and Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual standard of care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usual standard of care plus structured physical exercise training plus mediterranean-style diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Structured exercise training plus mediterranean diet</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with proven pathogenic BRCA1/2 mutation

        Exclusion Criteria:

          -  metastatic tumor disease

          -  life expectancy &lt;3 years

          -  clinically limiting cardiovascular or respiratory disease

          -  significant orthopedic disability which prevents from participating in the exercise
             training

          -  severe concomitant disease which prevents from participating in the group
             interventions

          -  Karnofsky index &lt;60

          -  VO2max &gt;150%

          -  Maximal exercise capacity &lt; 50 W

          -  food allergies which prevent from mediterranean diet

          -  vegan diet

          -  body mass index &lt;15 kg/m2

          -  pregnancy

          -  insufficient knowledge of German language

          -  insufficient compliance

          -  active participation in other interventional trials

          -  no informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marion Kiechle, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Halle, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan C Bischoff, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitaet Hohenheim, Stuttgart</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wolf-Dieter Gerber, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitaetsklinikum Schleswig-Holstein, Campus Kiel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Loeffler, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph Engel, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rita K Schmutzler, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alfons Meindl, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Schleswig-Holstein Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Technische Universitaet Muenchen</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.frauenklinik.med.tum.de/</url>
  </link>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2014</study_first_submitted>
  <study_first_submitted_qc>March 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <last_update_submitted>April 27, 2017</last_update_submitted>
  <last_update_submitted_qc>April 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hereditary breast and ovarian cancer (HBOC)</keyword>
  <keyword>BRCA1/2 mutation carriers</keyword>
  <keyword>Mediterranean diet</keyword>
  <keyword>Structured exercise training</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Hereditary Breast and Ovarian Cancer Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

